Response Differences between Human CD4+ and CD8+ T-Cells during CD28 Costimulation: Implications for Immune Cell-Based Therapies and Studies Related to the Expansion of Double-Positive T-Cells during Aging
- 1 September 2000
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 96 (3) , 187-197
- https://doi.org/10.1006/clim.2000.4902
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Large-Scale Production of CD4+ T Cells from HIV-1-Infected Donors After CD3/CD28 Costimulation*Journal of Hematotherapy, 1998
- Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative TumorsThe Journal of Experimental Medicine, 1998
- Bcl-xL Functions Downstream of Caspase-8 to Inhibit Fas- and Tumor Necrosis Factor Receptor 1-induced Apoptosis of MCF7 Breast Carcinoma CellsJournal of Biological Chemistry, 1998
- Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion?Immunology Today, 1997
- CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast KineticsThe Journal of Experimental Medicine, 1997
- CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xLImmunity, 1995
- Phenotypic Heterogeneity of Persistent Expansions of CD4+CD8+ T CellsClinical Immunology and Immunopathology, 1994
- Emergence of Double-Positive CD4/CD8 Cells from Adult Peripheral Blood Mononuclear Cells Infected with Human T Cell Leukemia Virus Type I (HTLV-I)Cellular Immunology, 1993
- A distinct large granular lymphocyte (LGL)/NK‐associated (NKa) abnormality characterized by membrane CD4 and CD8 coexpressionBritish Journal of Haematology, 1992
- Regulation of Interleukin-2 Gene Enhancer Activity by the T Cell Accessory Molecule CD28Science, 1991